Related Experiment Video
Updated: Aug 7, 2026
05:53
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
[Frailty in the older adults]
Hanne Nygaard1,2, Søren Kabell Nissen3,4, Anne Holm5,6
1Akutafdelingen, Københavns Universitetshospital - Bispebjerg og Frederiksberg Hospital.
Ugeskrift for Laeger
|August 6, 2026
Summary
Frailty, a key geriatric syndrome, signifies reduced health and increased vulnerability. Understanding frailty and using tools like the Clinical Frailty Scale aids personalized care for older adults.
Area of Science:
- Geriatric Medicine
- Clinical Gerontology
- Public Health
Background:
- Frailty is a prevalent geriatric condition characterized by diminished physiological reserve.
- It is linked to adverse outcomes, including functional decline, hospitalization, and mortality.
- Frailty impacts older adults across diverse healthcare settings.
Purpose of the Study:
- To review the concept and clinical relevance of frailty in older adults.
- To focus on the assessment of frailty, particularly using the Clinical Frailty Scale.
- To emphasize the role of frailty assessment in clinical decision-making and individualized treatment.
Main Methods:
- Literature review focusing on frailty assessment tools.
- Primary emphasis on the Clinical Frailty Scale.
- Synthesis of evidence on frailty's impact and management.
Main Results:
- Frailty is a significant predictor of negative health outcomes in older populations.
- The Clinical Frailty Scale is a practical tool for assessing frailty.
- Frailty assessment informs personalized care strategies.
Conclusions:
- Frailty assessment is crucial for understanding older patients' needs and risks.
- Clinical tools like the Clinical Frailty Scale facilitate evidence-based decision-making.
- Individualized treatment plans informed by frailty status can improve geriatric care.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:19The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...